|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Pfizer |
| Information provided by: | Pfizer |
| ClinicalTrials.gov Identifier: | NCT00601484 |
Purpose
The purpose of this study is to determine whether PF-04383119 is effective in the treatment of pain associated with interstitial cystitis.
| Condition | Intervention | Phase |
|
Cystitis, Interstitial Painful Bladder Syndrome |
Drug: PF-04383119 Drug: Placebo |
Phase II |
| MedlinePlus related topics: | Interstitial Cystitis |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Safety/Efficacy Study |
| Official Title: | A Phase 2, 16 Week, Multicenter, Randomized, Double Blind Placebo Controlled, Parallel Group Proof of Concept Study Evaluating the Efficacy and Safety of PF-04383119 for the Treatment of Pain Associated With Interstitial Cystitis |
| Estimated Enrollment: | 64 |
| Study Start Date: | March 2008 |
| Estimated Study Completion Date: | December 2008 |
| Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
| 2: Placebo Comparator |
Drug: Placebo
placebo IV, single dose
|
| 1: Experimental |
Drug: PF-04383119
PF-04383119 200 mcg/kg IV, single dose
|
Eligibility
| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Pfizer CT.gov Call Center | 1-800-718-1021 |
![]() |
Show 24 Study Locations |
| Pfizer |
| Study Director: | Pfizer CT.gov Call Center | Pfizer |
More Information
To obtain contact information for a study center near you, click here. 
  |
| Responsible Party: | Pfizer, Inc. ( Director, Clinical Trials Disclosure Group ) |
| Study ID Numbers: | A4091010 |
| First Received: | January 15, 2008 |
| Last Updated: | June 10, 2008 |
| ClinicalTrials.gov Identifier: | NCT00601484 |
| Health Authority: | United States: Food and Drug Administration |
|
|